{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:55:16Z","timestamp":1790114116580,"version":"4.0.1"},"reference-count":0,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"Abstract<\/jats:title>\n Background. Positron emission tomography-computed tomography (PET\/CT) with 18F-fluorocholine (FCH) is routinely performed in patients with prostate cancer. In this clinical context, foci of FCH uptake in the head or in the neck were considered as incidentalomas, except for those suggestive of multiple bone metastases.<\/jats:p>\n Results. In 8 patients the incidental focus corresponded to a benign tumour. The standard of truth was histology in two cases, correlative imaging with MRI in four cases, 99mTc-SestaMIBI scintigraphy, ultrasonography and biochemistry in one case and biochemistry including PTH assay in one case. The final diagnosis of benign tumours consisted in 3 pituitary adenomas, 2 meningiomas, 2 hyperfunctioning parathyroid glands and 1 thyroid adenoma. Malignancy was proven histologically in 2 other patients: 1 papillary carcinoma of the thyroid and 1 cerebellar metastasis.<\/jats:p>\n Conclusions. To the best of our knowledge, FCH uptake by pituitary adenomas or hyperfunctioning parathyroid glands has never been described previously. We thus discuss whether there might be a future indication for FCH PET\/ CT when one such tumour is already known or suspected: to detect a residual or recurrent pituitary adenoma after surgery, to guide surgery or radiotherapy of a meningioma or to localise a hyperfunctioning parathyroid gland. In these potential indications, comparative studies with reference PET tracers or with 99mTc-sestaMIBI in case of hyperparathyroidism could be undertaken.<\/jats:p>","DOI":"10.2478\/raon-2013-0075","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T16:17:47Z","timestamp":1382372267000},"page":"228-234","source":"Crossref","is-referenced-by-count":46,"title":["Incidental uptake of\n 18<\/sup>\n F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer"],"prefix":"10.2478","volume":"48","author":[{"given":"Marina","family":"Hodolic","sequence":"first","affiliation":[{"name":"Department for nuclear medicine, University Medical Centre, Ljubljana, Slovenia"},{"name":"Department for Nuclear Medicine, University Medical Centre, Zalo\u0161ka 2, SI-1000 Ljubljana, Slovenia. Phone: +386 1 522 35 48; Fax: +386 1 522 22 37"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Huchet","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Balogova","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"},{"name":"Comenius University, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Michaud","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"},{"name":"Universit\u00e9 Pierre et Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Kerrou","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Nataf","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"},{"name":"Radiopharmacie, H\u00f4pital Tenon, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Cimitan","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, National Cancer Institute CRO IRCCS, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Fettich","sequence":"additional","affiliation":[{"name":"Department for nuclear medicine, University Medical Centre, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Talbot","sequence":"additional","affiliation":[{"name":"M\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP, Paris, France"},{"name":"Universit\u00e9 Pierre et Marie Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2014,7,10]]},"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/raon\/48\/3\/article-p228.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2013-0075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:13:42Z","timestamp":1783898022000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2013-0075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,7,10]]},"published-print":{"date-parts":[[2014,9,1]]}},"alternative-id":["10.2478\/raon-2013-0075"],"URL":"https:\/\/doi.org\/10.2478\/raon-2013-0075","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]}}}